Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 11, 2015 9:19:16 PM
I think it is positive that Musclepharm is defending it's sales in America....and that the decline in sales from last year's very strong Q1 sales can be explained almost entirely by a decline in international sales.
It makes perfect sense to me that Musclepharm focuses on America and a few International markets with strong currencies like UK and Australia right now.
Many purchasers from Brazil and elsewhere, probably delayed purchases for later, given the multi year lows of the Euro, the Brazilian real and the Canadian Dollar during Q1....so, more sales from there should be expected in Q2 after the 5-10% strengthening of these currencies versus the US dollar.
With Musclepharm's future endorsement and sponsorship contracts, it's natural to focus primarily on America though.
Musclepharm's goal should be to break even on US sales alone, and let international sales be the cream on the top...with $10-15 million contribution each quarter.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM